DE

Communication from the Chairmen of the UPC Preparatory Committee and the EPO Select Committee dealing with the Unitary Patent of July 1, 2016

Communication from the Chairmen of the UPC Preparatory Committee and the EPO Select Committee dealing with the Unitary Patent.

The work of the Preparatory Committee and the Select Committee is far advanced and expected to be completed before the end of the year. Last week’s vote in the United Kingdom in favour of leaving the European Union has given rise to questions concerning the future of the Unified Patent Court and the Unitary Patent Protection.

At this stage it is too early to assess what the impact of this vote on the Unified Patent Court and the Unitary Patent Protection eventually could be.

This will largely depend on political decisions to be taken in the course of the next months. It has to be recalled that for the time being the United Kingdom remains a Member State of the European Union and a Signatory State of the Unified Patent Court Agreement.

Pending more clarity about different possible scenarios the chairmen of the Preparatory Committee and the Select Committee are of the opinion that the work dedicated to the technical implementation should continue to progress as envisaged, in accordance with the mandate of both Committees and in line with the clear wish of the user community to bring the Unified Patent Court and the Unitary Patent into operation as soon as possible.

(http://www.epo.org/about-us/organisation/select-committee.html text: Further information)

More articles from Dr. Raphael Bösl

The “Druckexemplar” determines the extend of protection conferred by a European patent

Dr. Raphael Bösl

Restoration of the Right of Priority under the PCT – different “Criterion for Restoration” before the USPTO and the EPO

Dr. Raphael Bösl

License Fees for a Compulsory License – Isentress II – German Federal Patent Court

Dr. Raphael Bösl

Follow-up: Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

EPO clarifies practice in the area of plant and animal patents

Dr. Raphael Bösl

EPO stays all proceedings in which the invention is a plant or animal obtained by an essentially biological process

Dr. Raphael Bösl

Communication from the Chairmen of the UPC Preparatory Committee and the EPO Select Committee dealing with the Unitary Patent of July 1, 2016

Dr. Raphael Bösl

Functional Features – Essential Features: A New Perspective under Article 84 EPC

Dr. Raphael Bösl

Plant Patent Protection and Plant Variety Protection – Two Independent IP Rights?

Dr. Raphael Bösl

A pitfall to supplement information incorporated by reference under the EPC

Dr. Raphael Bösl

EPO: claims directed to the use of a product produced by a process

Dr. Raphael Bösl

Enlarged Board of Appeal of the EPO decided on Clarity – expected decision now issued (G 3/14)

Dr. Raphael Bösl

Deautomation is not per se Inventive – an Exemption from the Rule under the EPC

Dr. Raphael Bösl

Four Step Approach in Determining Sufficiency of Disclosure of a Parameter under the EPC

Dr. Raphael Bösl

Refocus on the Interpretation of “Undue Burden” for the Determination of the Scope of Protection under the EPC

Dr. Raphael Bösl

Functional Definition of Compounds in Use Claims – Different Decisions in Germany and “Europe”

Dr. Raphael Bösl